
AVROBIO Inc is a biotechnology business based in the US. AVROBIO shares (AVRO) are listed on the NASDAQ and all prices are listed in US Dollars. AVROBIO employs 122 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in AVROBIO
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AVRO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

AVROBIO stock price (NASDAQ: AVRO)
Use our graph to track the performance of AVRO stocks over time.AVROBIO shares at a glance
Latest market close | $0.92 |
---|---|
52-week range | $0.74 - $11.00 |
50-day moving average | $0.94 |
200-day moving average | $2.84 |
Wall St. target price | $4.57 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.81 |
Buy AVROBIO shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AVROBIO stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AVROBIO price performance over time
Historical closes compared with the close of $0.92 from 2022-06-30
1 week (2022-06-24) | -6.12% |
---|---|
1 month (2022-05-28) | N/A |
3 months (2022-03-31) | -30.30% |
6 months (2021-12-31) | -76.10% |
1 year (2021-07-01) | -90.09% |
---|---|
2 years (2020-07-01) | -94.84% |
3 years (2019-07-01) | 16.14 |
5 years (2017-06-27) | N/A |
AVROBIO financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -36.02% |
Return on equity TTM | -64.91% |
Profit margin | 0% |
Book value | $3.35 |
Market capitalisation | $42.9 million |
TTM: trailing 12 months
AVROBIO share dividends
We're not expecting AVROBIO to pay a dividend over the next 12 months.
AVROBIO share price volatility
Over the last 12 months, AVROBIO's shares have ranged in value from as little as $0.74 up to $11. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AVROBIO's is 1.717. This would suggest that AVROBIO's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AVROBIO overview
AVROBIO, Inc. , a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
What percentage of AVROBIO is owned by insiders or institutions?Currently 2.683% of AVROBIO shares are held by insiders and 69.005% by institutions. How many people work for AVROBIO?
Latest data suggests 122 work at AVROBIO. When does the fiscal year end for AVROBIO?
AVROBIO's fiscal year ends in December. Where is AVROBIO based?
AVROBIO's address is: Building 300, Cambridge, MA, United States, 02139 What is AVROBIO's ISIN number?
AVROBIO's international securities identification number is: US05455M1009 What is AVROBIO's CUSIP number?
AVROBIO's Committee on Uniform Securities Identification Procedures number is: 05455M100
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert